Baystate Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Hold	0	–	–	–	965
2022 Q2	–	Hold	0	–	–	–	974